Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

950 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The interactions of docetaxel with tumor microenvironment.
Gupta R, Kadhim MM, Turki Jalil A, Qasim Alasheqi M, Alsaikhan F, Khalimovna Mukhamedova N, Alexis Ramírez-Coronel A, Hassan Jawhar Z, Ramaiah P, Najafi M. Gupta R, et al. Among authors: najafi m. Int Immunopharmacol. 2023 Jun;119:110214. doi: 10.1016/j.intimp.2023.110214. Epub 2023 Apr 29. Int Immunopharmacol. 2023. PMID: 37126985 Review.
Targets for improving tumor response to radiotherapy.
Mortezaee K, Parwaie W, Motevaseli E, Mirtavoos-Mahyari H, Musa AE, Shabeeb D, Esmaely F, Najafi M, Farhood B. Mortezaee K, et al. Among authors: najafi m. Int Immunopharmacol. 2019 Nov;76:105847. doi: 10.1016/j.intimp.2019.105847. Epub 2019 Aug 26. Int Immunopharmacol. 2019. PMID: 31466051 Review.
Abscopal effect in radioimmunotherapy.
Ashrafizadeh M, Farhood B, Eleojo Musa A, Taeb S, Rezaeyan A, Najafi M. Ashrafizadeh M, et al. Among authors: najafi m. Int Immunopharmacol. 2020 Aug;85:106663. doi: 10.1016/j.intimp.2020.106663. Epub 2020 Jun 7. Int Immunopharmacol. 2020. PMID: 32521494 Review.
Damage-associated molecular patterns in tumor radiotherapy.
Ashrafizadeh M, Farhood B, Eleojo Musa A, Taeb S, Najafi M. Ashrafizadeh M, et al. Among authors: najafi m. Int Immunopharmacol. 2020 Sep;86:106761. doi: 10.1016/j.intimp.2020.106761. Epub 2020 Jul 3. Int Immunopharmacol. 2020. PMID: 32629409 Review.
The interactions of paclitaxel with tumour microenvironment.
Yu DL, Lou ZP, Ma FY, Najafi M. Yu DL, et al. Among authors: najafi m. Int Immunopharmacol. 2022 Apr;105:108555. doi: 10.1016/j.intimp.2022.108555. Epub 2022 Feb 1. Int Immunopharmacol. 2022. PMID: 35121223 Review.
Modulation of the immune system by melatonin; implications for cancer therapy.
Moslehi M, Moazamiyanfar R, Dakkali MS, Rezaei S, Rastegar-Pouyani N, Jafarzadeh E, Mouludi K, Khodamoradi E, Taeb S, Najafi M. Moslehi M, et al. Among authors: najafi m. Int Immunopharmacol. 2022 Jul;108:108890. doi: 10.1016/j.intimp.2022.108890. Epub 2022 May 24. Int Immunopharmacol. 2022. PMID: 35623297 Review.
950 results